Eli Lilly's Alzheimer's drug cleared in Australia despite setback for Biogen
Source: SeekingAlpha
2025-05-22 07:12:05 ET
More on Eli Lilly, Biogen, etc.
- Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound
- Eli Lilly and Company (LLY) BofA Securities 2025 Health Care Conference Call Transcript
- Eisai Co., Ltd. (ESALF) Q4 2025 Earnings Call Transcript
- Cigna’s Evernorth caps weight-loss drug copays at $200/month
- FDA offering states help for Canada drug importation proposals
Read the full article on Seeking Alpha
For further details see:
Eli Lilly’s Alzheimer’s drug cleared in Australia despite setback for Biogen
BioArctic
NASDAQ: BRCTF
BRCTF Trading
0.0% G/L:
$33.02 Last:
108 Volume:
$33.02 Open:
